Bayer Aktiengesellschaft (BAYRY)
| Market Cap | 42.13B |
| Revenue (ttm) | 53.51B |
| Net Income (ttm) | -4.25B |
| Shares Out | n/a |
| EPS (ttm) | -4.33 |
| PE Ratio | n/a |
| Forward PE | 8.63 |
| Dividend | 0.02 (0.22%) |
| Ex-Dividend Date | Apr 28, 2026 |
| Volume | 122,273 |
| Average Volume | 1,422,673 |
| Open | 10.85 |
| Previous Close | 10.77 |
| Day's Range | 10.59 - 10.85 |
| 52-Week Range | 6.20 - 14.85 |
| Beta | 0.89 |
| RSI | 34.08 |
| Earnings Date | May 12, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge... [Read more]
Financial Performance
In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.
Financial numbers in EUR Financial StatementsNews
Bayer Faces Critical Supreme Court Debate Over Roundup Lawsuits
Bayer Faces Critical Supreme Court Debate Over Roundup Lawsuits
Bayer Faces Supreme Court Challenges Over Roundup Lawsuits (BAYRY)
Bayer Faces Supreme Court Challenges Over Roundup Lawsuits (BAYRY)
Bayer Stock Plunges As Supreme Court Wrestles With Roundup Cancer Suits
Bayer AG (OTC: BAYRY) shares took a steep dive late Monday afternoon as the U.S. Supreme Court grappled with whether to shield the chemical giant from tens of thousands of cancer lawsuits involving i...
Bayer shares slide after U.S. Supreme Court split over Bayer's fight against Roundup lawsuits
Shares in chemicals giant Bayer fell as much as 6.5% on Tuesday after the U.S. Supreme Court appeared split over what view it will form in Bayer's fight against Roundup lawsuits.
Bayer Faces Legal Challenge Over Roundup Liability
Bayer Faces Legal Challenge Over Roundup Liability
With Bayer at US Supreme Court, MAHA rallies against pesticides
"Make America Healthy Again" activists rallied at the U.S. Supreme Court building on Monday against Bayer as the justices heard arguments in the German company's effort to end thousands of lawsuits t...
Bayer Faces Supreme Court Hearing on Roundup Liability
Bayer Faces Supreme Court Hearing on Roundup Liability
US Supreme Court hears Bayer's fight against Roundup lawsuits
The U.S. Supreme Court is set on Monday to consider Bayer AG's effort to shut down thousands of lawsuits accusing the company of failing to warn users that the active ingredient in its Roundup weedki...
Bayer (BAYRY) Faces Supreme Court Hearings on Roundup Lawsuits
Bayer (BAYRY) Faces Supreme Court Hearings on Roundup Lawsuits
Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits?
The U.S. Supreme Court hears arguments on Monday in Bayer's bid to limit thousands of lawsuits alleging that the German company's Roundup weedkiller causes cancer in a case that is one part of sprawli...
Bayer Advances $7.25 Billion Roundup Settlement Ahead of Key Supreme Court Ruling
Bayer Advances $7.25 Billion Roundup Settlement Ahead of Key Supreme Court Ruling
Buy or Goodbye?: Alphabet, Nestle, Bayer und SAP - Die Analystenstimmen des Tages
Alphabet, Nestle, Bayer und SAP: Die wichtigsten Analysten-Updates im Überblick.
Bayer (BAYRY) Faces Crucial $7.5 Billion Settlement Decision in Roundup Litigation
Bayer (BAYRY) Faces Crucial $7.5 Billion Settlement Decision in Roundup Litigation
The Cancer Victims Who Could Sink Bayer's Roundup Settlement
With thousands of cases piling up in U.S. courts, the company's relief plans still face hurdles.
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in hal...
Bayer's Lawsuit Against Johnson & Johnson Over Prostate Cancer Drug Advertising Dismissed
Bayer's Lawsuit Against Johnson & Johnson Over Prostate Cancer Drug Advertising Dismissed
U.S. judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer’s request for an injunction to block Johnson & Johnson’s alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in half...
U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims
A federal judge rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer i...
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is proud to support the Simon Fraser University (SFU) School of Medicine - the first medical school in Western Canada in nearly 60 years. The new sc...
Bayer US head says tariffs will not affect its 2026 forecasts
A top Bayer AG executive said on Tuesday the German drugmaking and crop science company saw no need to adjust its 2026 forecasts because of tariffs on imported pharmaceuticals announced by the U.S. ...
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regim...
Bayer Weighs U.S. Pharma Expansion as Turnaround Picks Up Speed
How Bayer Uses AI to Avoid Sending Customers to its Competition
As generative AI and creators take a bigger hand in producing creative work, brand managers face a crucial question: Who’s watching to ensure its all working together to build brand […]
National Advertising Division Recommends Bayer Modify or Discontinue Certain One A Day Men's Pre-Conception Health Complete Multivitamin Claims
Following a challenge brought by OLLY PBC, BBB National Programs' National Advertising Division recommended that Bayer HealthCare LLC discontinue or modify certain claims for its One A Day® Men's Pre-...
Bayer Announces Leadership Change Within Pharmaceuticals' Worldwide Markets Organization in the U.S. to Support Company's Full Growth Potential
Nelson Ambrogio appointed to lead U.S. pharmaceuticals business, Bayer's largest pharmaceutical growth market Appointment supports Bayer Pharmaceuticals' strategy to renew top-line growth and maxi...